This complete guide to Bipolar Androgen Therapy (BAT) should be your stepping-off point if you are interested in using BAT to treat your castrate-resistant prostate cancer (CrPC).
Several men have asked us if they are better off having 177Lu-PSMA-617 (Pluvicto) or Xofigo, a radiopharmaceutical drug that treats bone metastases. There is no simple answer, and the answer is not the same for each of us. Making a sound decision can be helped by understanding the mode of action and the limits of each treatment.
LYNPARZA (olaparib) and RUBRACA (rucaparib) are PARP Inhibitors that were FDA approved in May of 2020 for men with castrate resistant prostate cancer who also have certain genetic mutations. The FDA also approved certain Companion Diagnostic genetic tests to go along with the decision making to use these PARP Inhibitors.
There is a lot of information now available with these recent developments which makes decision making confusing.
There are several possible side effects that can result from receiving radiation treatment. The most common of these side effects include the development of scar tissue that makes it hard to urinate (pee), defecate (poop), and in some instances, link the activity of either peeing and pooping together; bladder or colon bleeding and diarrhea.
Given the importance of knowing about your germline genetics, Cancer ABCs wants you to know that if you have prostate cancer there is currently a genetic company, Invitae that is offering you an opportunity to have your germline genetics tested for free. They will also offer you, for free, access to a genetic counselor
A meta-analysis was performed to evaluate the treatment efficacy of stereotactic body radiotherapy (SBRT) in men with oligometastatic prostate cancer recurrence and to assess whether there is any relationship between biologically effective dose (BED) (how much radiation to use) and local control (LC) (the success of the radiation treatment in controlling the existing metastases as well as the development of new local metastases).
There are several possible side effects that can result from receiving radiation treatment. The most common of these side effects include the development of scar tissue that makes it hard to urinate (pee), defecate (poop), and in some instances, link the activity of either peeing and pooping together; bladder or colon bleeding and diarrhea.
The only way to make these significant clinical decisions with confidence is to be sure that before assuming that you are castrate resistant your testosterone levels must be confirmed by either mass spectrometry or an immunoassay method that has been validated at low testosterone levels and interpreted with caution before any changes are made to treatment management.
Testing for genetic weaknesses in repairing DNA could pick out men who may benefit from a new type of targeted nuclear medicine, a new study reports.
An emerging class of drugs are made up of a radioactive particle that can kill cells attached to a ‘homing device’ to seek out cancers by detecting the presence of a target molecule on their surface.
There are Solutions
One of the possible side effects you might experience after having prostate cancer surgery or radical prostatectomy or RP is incontinence. Incontinence or the unwanted leakage of urine can be just a minor dripping of urine, or it can be the complete and total loss of control of your urine.
